SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates

被引：425
作者：
Poland, Gregory A. [1 ,2 ]
Ovsyannikova, Inna G. [1 ,2 ]
Kennedy, Richard B. [1 ,2 ]
机构：
[1] Mayo Clin, Mayo Clin Vaccine Res Grp, Rochester, MN USA
[2] Mayo Clin, Div Gen Internal Med, Rochester, MN USA
来源：
LANCET | 2020年 / 396卷 / 10262期
关键词：
ANTIBODY-DEPENDENT ENHANCEMENT; COVID-19; INFECTION; DISEASE; CELLS;
D O I：
10.1016/S0140-6736(20)32137-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Understanding immune responses to severe acute respiratory syndrome coronavirus 2 is crucial to understanding disease pathogenesis and the usefulness of bridge therapies, such as hyperimmune globulin and convalescent human plasma, and to developing vaccines, antivirals, and monoclonal antibodies. A mere 11 months ago, the canvas we call COVID-19 was blank. Scientists around the world have worked collaboratively to fill in this blank canvas. In this Review, we discuss what is currently known about human humoral and cellular immune responses to severe acute respiratory syndrome coronavirus 2 and relate this knowledge to the COVID-19 vaccines currently in phase 3 clinical trials.
引用
收藏
页码：1595 / 1606
页数：12
相关论文
共 89 条
  • [21] The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement
    Hotez, Peter J.
    Bottazzi, Maria Elena
    Corry, David B.
    [J]. MICROBES AND INFECTION, 2020, 22 (4-5) : 165 - 167
  • [22] Immunoglobulin G antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response
    Iankov, Ianko D.
    Pandey, Manoj
    Harvey, Mary
    Griesmann, Guy E.
    Federspiel, Mark J.
    Russell, Stephen J.
    [J]. JOURNAL OF VIROLOGY, 2006, 80 (17) : 8530 - 8540
  • [23] Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19
    Ibarrondo, F. Javier
    Fulcher, Jennifer A.
    Yang, Otto O.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (11) : 1085 - 1087
  • [24] An mRNA Vaccine against SARS-CoV-2-Preliminary Report
    Jackson, L. A.
    Anderson, E. J.
    Rouphael, N. G.
    Roberts, P. C.
    Makhene, M.
    Coler, R. N.
    McCullough, M. P.
    Chappell, J. D.
    Denison, M. R.
    Stevens, L. J.
    Pruijssers, A. J.
    McDermott, A.
    Flach, B.
    Doria-Rose, N. A.
    Corbett, K. S.
    Morabito, K. M.
    O'Dell, S.
    Schmidt, S. D.
    Swanson, P. A.
    Padilla, M.
    Mascola, J. R.
    Neuzil, K. M.
    Bennett, H.
    Sun, W.
    Peters, E.
    Makowski, M.
    Albert, J.
    Cross, K.
    Buchanan, W.
    Pikaart-Tautges, R.
    Ledgerwood, J. E.
    Graham, B. S.
    Beigel, J. H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (20) : 1920 - 1931
  • [25] Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH-and Cysteine Protease-Independent FcγR Pathway
    Jaume, Martial
    Yip, Ming S.
    Cheung, Chung Y.
    Leung, Hiu L.
    Li, Ping H.
    Kien, Francois
    Dutry, Isabelle
    Callendret, Benoit
    Escriou, Nicolas
    Altmeyer, Ralf
    Nal, Beatrice
    Daeron, Marc
    Bruzzone, Roberto
    Peiris, J. S. Malik
    [J]. JOURNAL OF VIROLOGY, 2011, 85 (20) : 10582 - 10597
  • [26] Gender Differences in Patients With COVID-19: Focus on Severity and Mortality
    Jin, Jian-Min
    Bai, Peng
    He, Wei
    Wu, Fei
    Liu, Xiao-Fang
    Han, De-Min
    Liu, Shi
    Yang, Jin-Kui
    [J]. FRONTIERS IN PUBLIC HEALTH, 2020, 8
  • [27] Kaneko Naoki, 2020, SSRN, P3652322, DOI [10.1016/j.cell.2020.08.025, 10.2139/ssrn.3652322]
  • [28] Antibody-dependent enhancement of severe dengue disease in humans
    Katzelnick, Leah C.
    Gresh, Lionel
    Halloran, M. Elizabeth
    Carlos Mercado, Juan
    Kuan, Guillermina
    Gordon, Aubree
    Balmaseda, Angel
    Harris, Eva
    [J]. SCIENCE, 2017, 358 (6365) : 929 - 932
  • [29] COVID-19 Vaccine: A comprehensive status report
    Kaur, Simran Preet
    Gupta, Vandana
    [J]. VIRUS RESEARCH, 2020, 288
  • [30] Kuri-Cervantes Leticia, 2020, bioRxiv, DOI 10.1101/2020.05.18.101717
123456789